QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa)

Trial Profile

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2017

At a glance

  • Drugs Mesalazine (Primary)
  • Indications Ulcerative proctitis
  • Focus Therapeutic Use
  • Acronyms QUARTZ
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 28 Apr 2017 Status changed from recruiting to active, no longer recruiting.
    • 04 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 01 Dec 2015 Planned initiation date changed from 1 Nov 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top